McCulloh Russell J, Smitherman Sarah E, Koehn Kristin L, Alverson Brian K
Division of Infectious Diseases, Children's Mercy Hospital, Kansas City, MO; University of Missouri-Kansas City School of Medicine, Kansas City, MO.
Pediatr Pulmonol. 2014 Jul;49(7):688-94. doi: 10.1002/ppul.22835. Epub 2013 Jul 19.
Acute bronchiolitis is a common illness accounting for $500 million annually in hospitalizations. Despite the frequency of bronchiolitis, its diagnosis and management is variable. To address this variability, the American Academy of Pediatrics (AAP) published an evidence-based practice management guideline for bronchiolitis in 2006.
Assess for changes in physician behavior in the management of bronchiolitis before and after publication of the 2006 AAP bronchiolitis guideline.
A retrospective chart review was performed at two academic medical centers of children <24 months of age admitted to the hospital with a primary or secondary discharge diagnosis of bronchiolitis. Pre-guideline charts were gathered from 2004 to 2005 and post-guideline charts from 2007 to 2008. Evaluation and therapeutic interventions prior to and during hospitalization were analyzed. Data were analyzed using chi-squared analysis for categorical variables, Mann-Whitney testing for continuous variables.
One thousand two hundred thirty-three patients met inclusion criteria. Diagnostic laboratory testing rates did not decline after guideline publication. The number of chest X-rays obtained decreased from 72.9% to 66.7% post-guidelines (P = 0.02). Fewer children received a trial of racemic epinephrine (17.8% vs. 12.2%, P = 0.006) or albuterol (81.6% vs. 72.6%, P < 0.0001) post-guidelines, and physicians more often discontinued albuterol when documented ineffective in the post-guidelines period (28.6% vs. 78.9%, P < 0.0001). Corticosteroid use in children without a history of RAD or asthma dropped post-guidelines (26.5% vs. 17.5%, P < 0.0001).
A modest change in physician behavior in the inpatient management of bronchiolitis was seen post-guidelines. Additional health care provider training and education is warranted to reduce unnecessary interventions and healthcare resources use.
急性细支气管炎是一种常见疾病,每年住院治疗费用达5亿美元。尽管细支气管炎很常见,但其诊断和治疗方法却各不相同。为解决这种差异,美国儿科学会(AAP)于2006年发布了一项基于证据的细支气管炎实践管理指南。
评估2006年AAP细支气管炎指南发布前后医生在细支气管炎管理方面行为的变化。
在两家学术医疗中心对年龄小于24个月、因原发性或继发性出院诊断为细支气管炎而住院的儿童进行回顾性病历审查。指南发布前的病历收集于2004年至2005年,指南发布后的病历收集于2007年至2008年。分析住院前和住院期间的评估及治疗干预措施。使用卡方分析对分类变量进行数据分析,使用曼-惠特尼检验对连续变量进行数据分析。
1233名患者符合纳入标准。指南发布后诊断性实验室检查率并未下降。指南发布后,进行胸部X光检查的人数从72.9%降至66.7%(P = 0.02)。指南发布后,接受消旋肾上腺素试验的儿童减少(17.8%对12.2%,P = 0.006),接受沙丁胺醇治疗的儿童也减少(81.6%对72.6%,P < 0.0001),并且在指南发布后的时期,当记录显示沙丁胺醇无效时,医生更常停用该药(28.6%对78.9%,P < 0.0001)。指南发布后,无复发性喘鸣或哮喘病史的儿童使用皮质类固醇的情况有所下降(26.5%对17.5%,P < 0.0001)。
指南发布后,医生在细支气管炎住院管理方面的行为有适度变化。有必要对医疗保健提供者进行更多培训和教育,以减少不必要的干预措施和医疗资源的使用。